Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature. (2023)
Attributed to:
Child Growth and development
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/ejendo/lvad039
PubMed Identifier: 36943306
Publication URI: http://europepmc.org/abstract/MED/36943306
Type: Journal Article/Review
Volume: 188
Parent Publication: European journal of endocrinology
Issue: 4
ISSN: 0804-4643